Clinical Trial

Evaluation of Lifestyle Modification on Cardiovascular Risk

Study acronym: GHRexD
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 2, 2024 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study proposes to examine the independent and combined effects of an 8-week home-based, equipment-free HIIT exercise intervention with/without Mediterranean diet through ghrelin-mediated alteration in overweight and obese metabolic women to improve cardiovascular-risk related markers and metabolic risk factors.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-06-09; most recent amendment 2024-11-27.
Status change: Recruiting → Active, Not Recruiting 2024-11-27
Trial Details
NCT Number NCT05417698
Lead Sponsor Swansea University
Conditions Metabolic Syndrome, Menopause, Cardiovascular Diseases, Obesity, Type2diabetes
Enrollment 60 participants
Start Date 2022-08-15
Primary Completion 2025-08-15 (estimated)
Study Completion 2025-08-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-02